CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,953,000 | +84.1% | 134,596 | -11.7% | 0.07% | +111.4% |
| Q2 2022 | $3,776,000 | -33.2% | 152,368 | -32.4% | 0.04% | +6.1% |
| Q1 2022 | $5,651,000 | -1.3% | 225,404 | +43.4% | 0.03% | +10.0% |
| Q4 2021 | $5,724,000 | +65.7% | 157,221 | -22.2% | 0.03% | +25.0% |
| Q3 2021 | $3,455,000 | +20.5% | 202,076 | -5.6% | 0.02% | +33.3% |
| Q2 2021 | $2,868,000 | -3.1% | 214,166 | +270.7% | 0.02% | -10.0% |
| Q1 2021 | $2,961,000 | +211.4% | 57,780 | +276.3% | 0.02% | +122.2% |
| Q4 2020 | $951,000 | -58.0% | 15,355 | -62.8% | 0.01% | -66.7% |
| Q3 2020 | $2,262,000 | +168.0% | 41,275 | +181.4% | 0.03% | +125.0% |
| Q2 2020 | $844,000 | +82.3% | 14,670 | +25.4% | 0.01% | +71.4% |
| Q4 2019 | $463,000 | -43.6% | 11,697 | -86.7% | 0.01% | -50.0% |
| Q2 2019 | $821,000 | – | 88,256 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |